Hartford Sustainable Income ETF (HSUN) Chart & Stock Price History → Jim Cramer’s “The Biggest Drug Ever” (From Behind the Markets) (Ad) Free HSUN Stock Alerts $33.32 -0.10 (-0.30%) (As of 04/25/2024 ET) Add Compare Share Share ChartStock AnalysisChartDividendHoldingsOwnershipStock AnalysisChartDividendHoldingsOwnership Hartford Sustainable Income ETF Stock Price Performance5 Day Performance+0.12%1 Month Performance-2.31%3 Month Performance-1.88%6 Month Performance+5.11%Year-To-Date Performance-1.76%1 Year Performance-0.86% Receive HSUN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Hartford Sustainable Income ETF and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsJim Cramer’s “The Biggest Drug Ever”This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.Unlock the details of this groundbreaking opportunity here... HSUN Stock Chart for Friday, April, 26, 2024 HSUN Chart by TradingView Hartford Sustainable Income ETF Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/25/2024$33.42$33.42-0.01%$33.42$33.421,030 shs$55.14 million04/24/2024$33.31$33.42+0.32%$33.42$33.421,030 shs$55.14 million04/23/2024$33.28$33.31+0.09%$33.31$33.3144 shs$54.97 million04/22/2024$33.28$33.28$33.28$33.281,339 shs$54.91 million04/19/2024$33.26$33.26$33.27$33.251,339 shs$53.21 million04/18/2024$33.25$33.26+0.03%$33.27$33.251,339 shs$53.21 million Get the Latest News and Ratings for HSUN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hartford Sustainable Income ETF and its competitors with MarketBeat's FREE daily newsletter. 04/17/2024$33.21$33.25+0.14%$33.25$33.242,067 shs$53.20 million04/16/2024$33.28$33.21-0.23%$33.21$33.211,130 shs$53.13 million04/15/2024$33.53$33.28-0.74%$33.31$33.271,463 shs$53.25 million04/12/2024$33.50$33.50$33.50$33.50681 shs$53.60 million04/11/2024$33.61$33.50-0.33%$33.50$33.48992 shs$53.60 million04/10/2024$33.81$33.61-0.59%$33.61$33.5420,956 shs$53.78 million04/09/2024$33.83$33.81-0.06%$33.83$33.741,177 shs$54.10 million04/08/2024$33.81$33.83+0.07%$33.83$33.741,177 shs$54.13 million04/05/2024$33.83$33.88+0.15%$33.88$33.8825 shs$54.21 million04/04/2024$33.83$33.83$33.84$33.785,559 shs$54.13 million04/03/2024$33.80$33.83+0.09%$33.84$33.785,559 shs$54.13 million04/02/2024$33.92$33.80-0.35%$33.83$33.783,051 shs$54.08 million04/01/2024$34.04$33.92-0.35%$33.92$33.92134 shs$54.27 million03/29/2024$34.04$34.04$34.08$34.03505 shs$54.46 million03/28/2024$34.02$34.04+0.06%$34.08$34.03505 shs$54.46 million03/27/2024$34.11$34.02-0.26%$34.04$34.021,336 shs$54.43 million03/26/2024$34.15$34.11-0.13%$34.11$34.1114 shs$54.57 million03/25/2024$34.15$34.15$34.15$34.1589 shs$54.64 million03/22/2024$34.06$34.06$34.09$34.067,314 shs$54.50 million03/21/2024$34.03$34.06+0.10%$34.08$34.066,895 shs$54.50 million03/20/2024$34.03$34.03$34.03$34.031 shs$54.44 million03/19/2024$33.93$34.03+0.29%$34.03$34.031 shs$54.44 million03/18/2024$33.94$33.93-0.04%$33.95$33.931,010 shs$54.28 million03/15/2024$33.99$33.94-0.15%$33.98$33.948,366 shs$54.30 million03/14/2024$34.12$33.99-0.37%$34.02$33.99254 shs$54.38 million03/13/2024$34.08$34.12+0.11%$34.12$34.12240 shs$54.59 million03/12/2024$34.13$34.08-0.15%$34.08$34.0823 shs$54.53 million03/11/2024$34.11$34.13+0.07%$34.13$34.134 shs$54.61 million03/08/2024$34.06$34.06-0.01%$34.06$34.061,684 shs$54.49 million03/07/2024$33.99$34.06+0.21%$34.06$34.061,684 shs$54.50 million03/06/2024$33.99$33.99$34.02$33.966,804 shs$54.38 million03/05/2024$33.91$33.99+0.24%$33.99$33.9971 shs$54.38 million03/04/2024$33.88$33.91+0.09%$33.91$33.89419 shs$54.26 million03/01/2024$33.81$33.82+0.03%$33.82$33.782,465 shs$54.11 millionJim Cramer’s “The Biggest Drug Ever” (Ad)This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.Unlock the details of this groundbreaking opportunity here...02/29/2024$33.76$33.81+0.16%$33.83$33.811,119 shs$54.10 million02/28/2024$33.94$33.76-0.54%$33.77$33.7111,911 shs$54.01 million02/27/2024$33.94$33.94$34.02$33.926,636 shs$54.30 million02/26/2024$33.99$33.94-0.15%$34.02$33.926,636 shs$54.30 million02/23/2024$33.89$33.99+0.29%$34.02$33.99509 shs$54.38 million02/22/2024$33.84$33.89+0.15%$33.90$33.88315 shs$54.23 million02/21/2024$33.88$33.84-0.12%$33.84$33.8485 shs$54.14 million02/20/2024$33.80$33.88+0.24%$33.90$33.8413,965 shs$54.21 million02/19/2024$33.80$33.80$33.82$33.803,579 shs$54.08 million02/16/2024$33.85$33.80-0.15%$33.82$33.803,579 shs$54.08 million02/15/2024$33.77$33.85+0.24%$33.85$33.85821 shs$54.16 million02/14/2024$33.77$33.77+0.01%$33.77$33.77121 shs$54.03 million02/13/2024$33.90$33.77-0.38%$33.78$33.76420 shs$54.03 million02/12/2024$33.87$33.90+0.09%$33.90$33.868,268 shs$54.23 million02/09/2024$33.85$33.87+0.06%$33.87$33.825,304 shs$54.18 million02/08/2024$33.86$33.85-0.04%$33.86$33.839,488 shs$54.15 million02/07/2024$33.80$33.86+0.18%$33.91$33.862,499 shs$54.18 million02/06/2024$33.79$33.80+0.03%$33.82$33.8010,243 shs$54.08 million02/05/2024$33.84$33.79-0.16%$33.83$33.793,597 shs$54.06 million02/02/2024$34.05$33.84-0.62%$33.90$33.8334,520 shs$54.15 million02/01/2024$34.01$34.05+0.13%$34.05$34.0213,792 shs$54.49 million01/31/2024$33.91$34.01+0.29%$34.01$34.00838 shs$54.42 million01/30/2024$33.85$33.91+0.18%$33.91$33.887,292 shs$54.26 million01/29/2024$33.96$33.85-0.32%$33.85$33.797,624 shs$54.16 million01/26/2024$33.89$33.96+0.21%$33.96$33.914,825 shs$54.34 million01/25/2024$33.72$33.89+0.50%$33.89$33.8429,144 shs$54.22 million Related Companies: KGRN Stock Price Chart DRUP Stock Price Chart FITE Stock Price Chart AGNG Stock Price Chart DTCR Stock Price Chart GBUY Stock Price Chart WOMN Stock Price Chart GLRY Stock Price Chart CRPT Stock Price Chart PEXL Stock Price Chart Receive HSUN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Hartford Sustainable Income ETF and its competitors with MarketBeat's FREE daily newsletter. This page (BATS:HSUN) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressThe only accurate crypto trading system I know …Weiss RatingsThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hartford Sustainable Income ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.